Efficacy News and Research

RSS
AI-designed drug shows early promise for lung fibrosis patients in clinical trial

AI-designed drug shows early promise for lung fibrosis patients in clinical trial

New technique improve success rates in treating strokes and other clot-related diseases

New technique improve success rates in treating strokes and other clot-related diseases

AI and clinicians compared in handling complex medical cases

AI and clinicians compared in handling complex medical cases

New marker identifies the functional maturity and heterogeneity of stem cell–derived islet organoids

New marker identifies the functional maturity and heterogeneity of stem cell–derived islet organoids

Key proteins and pathways drive the success of CAR-T cell therapy

Key proteins and pathways drive the success of CAR-T cell therapy

Navigating the dual role of B cells in tumor immunity

Navigating the dual role of B cells in tumor immunity

Early camizestrant therapy keeps advanced breast cancer in check

Early camizestrant therapy keeps advanced breast cancer in check

Real world data confirms effectiveness of nirsevimab in young infants with bronchiolitis

Real world data confirms effectiveness of nirsevimab in young infants with bronchiolitis

PfSPZ-LARC2 malaria vaccine advances to new age groups after successful safety review

PfSPZ-LARC2 malaria vaccine advances to new age groups after successful safety review

Myeloid cells shape tumor microenvironments and influence cancer progression

Myeloid cells shape tumor microenvironments and influence cancer progression

Transforming IBS treatment through psychedelic medicine

Transforming IBS treatment through psychedelic medicine

Asthma drug once hoped to treat alcohol use disorder fails to meet expectations in UCLA trial

Asthma drug once hoped to treat alcohol use disorder fails to meet expectations in UCLA trial

How soy and gut microbes alter cancer treatment results

How soy and gut microbes alter cancer treatment results

First-in-class antibody-drug conjugate shows high response rates in rare blood cancer trial

First-in-class antibody-drug conjugate shows high response rates in rare blood cancer trial

Flea protein inspires breakthrough in preventing medical implant infections

Flea protein inspires breakthrough in preventing medical implant infections

Engineered viruses and gene therapy halt tumor growth and extend survival in mice

Engineered viruses and gene therapy halt tumor growth and extend survival in mice

New combination treatment offers hope for immune checkpoint blockade resistant skin cancers

New combination treatment offers hope for immune checkpoint blockade resistant skin cancers

Expert review reveals how to fuel triathletes for optimal results

Expert review reveals how to fuel triathletes for optimal results

Avelumab and cetuximab combination shows promise in phase II skin cancer trial

Avelumab and cetuximab combination shows promise in phase II skin cancer trial

Combination treatment extends progression-free survival in advanced skin cancer

Combination treatment extends progression-free survival in advanced skin cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.